Bolisetty S, Gupta J M, Graham G G, Salonikas C, Naidoo D
Department of Neonatology, Royal Hospital for Women, Sydney, Australia.
Acta Paediatr. 1998 Sep;87(9):960-2. doi: 10.1080/080352598750031626.
Six healthy lactating mothers who gave birth to preterm infants at a median post conceptional age of 29.5 (range 26-30) weeks were given 2.5 mg phylloquinone (vitamin K1) orally daily for 2 weeks beginning at a median postconceptional age of 31.5 (range 28-32) weeks. Phylloquinone was measured in the breastmilk daily for 14 d. Trough plasma phylloquinone concentrations were also determined on four occasions. Phylloquinone levels in the breastmilk increased from a baseline of 3 +/- 2.3 ng ml(-1) to 22.6 +/- 16.3 ng ml(-1) (mean +/- SD) after the first dose (p < 0.05); a gradual increase was noted until phylloquinone levels reached a plateau of 64.2 +/- 31.4 ng ml(-1) after the sixth daily dose.
六位健康的哺乳期母亲,她们所生早产儿的孕龄中位数为29.5周(范围26 - 30周),从孕龄中位数31.5周(范围28 - 32周)开始,每天口服2.5毫克叶绿醌(维生素K1),持续2周。连续14天每天测量母乳中的叶绿醌含量。还在四个时间点测定了血浆叶绿醌的谷浓度。首次给药后,母乳中叶绿醌水平从基线的3±2.3纳克/毫升升至22.6±16.3纳克/毫升(均值±标准差)(p<0.05);叶绿醌水平持续逐渐升高,直至每日第六次给药后达到64.2±31.4纳克/毫升的平台期。